4//SEC Filing
Jorgensen Lars Fruergaard 4
Accession 0001209191-10-050022
CIK 0001129425other
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 1:54 PM ET
Size
9.9 KB
Accession
0001209191-10-050022
Insider Transaction Report
Form 4
ZYMOGENETICS INCZGEN
Jorgensen Lars Fruergaard
Director
Transactions
- Disposition from Tender
Common Stock
2010-10-08$9.75/sh−23,009,861$224,346,145→ 0 total(indirect: By Novo Nordisk A/S)
Footnotes (1)
- [F1]Lars Fruergaard Jorgensen is the Senior VP, Information Technology and Corporate Development of Novo Nordisk A/S and may be deemed to have shared voting and investment power with respect to the 22,143,320 shares sold by Novo Nordisk A/S. In addition, Novo A/S, the parent holding company of Novo Nordisk A/S, sold 866,541 shares. Mr. Jorgensen disclaims beneficial ownership of the shares held by Novo Nordisk A/S and Novo A/S.
Issuer
ZYMOGENETICS INC
CIK 0001129425
Entity typeother
Related Parties
1- filerCIK 0001494565
Filing Metadata
- Form type
- 4
- Filed
- Oct 11, 8:00 PM ET
- Accepted
- Oct 12, 1:54 PM ET
- Size
- 9.9 KB